Location History:
- Mitaka, JP (2001 - 2004)
- Tokyo, JP (2015)
Company Filing History:
Years Active: 2001-2015
Title: **The Innovative Mind of Nobuyuki Ise: A Titan in Cancer Research**
Introduction
Nobuyuki Ise is a prominent inventor based in Tokyo, Japan, recognized for his significant contributions to cancer research. His innovative work has led to the development of several patents that aim to improve therapeutic outcomes for cancer patients. With a total of four patents to his name, Ise is a crucial figure in the field of oncology.
Latest Patents
Ise's latest patents highlight his dedication to advancing cancer treatments. One noteworthy invention is a **diagnostic marker for the effect of anticancer agents**, which allows for convenient determination of the therapeutic effects of these agents on cancer. This invention utilizes a substance with an affinity for a fragment of the extracellular domain of c-MET and provides a method to measure its concentration in biological samples, thus aiding in assessing the drug's efficiency.
Another significant patent involves a **method for identifying oncogenes** and a **method of screening oncogene-targeting drugs**. This groundbreaking methodology facilitates the development of superior anti-cancer drugs by establishing artificial cells from cancer cells treated with an expression vector for foreign oncogenes. The patent outlines a process for evaluating new drug substances that may inhibit the proliferation of these engineered cancer cells.
Career Highlights
Ise is currently associated with Fujirebio Inc., where his innovative research is continuously shaping the landscape of cancer diagnostics and therapeutics. His role emphasizes the need for advancements in identifying and targeting oncogenes, a crucial step in developing tailored anticancer therapies.
Collaborations
Nobuyuki Ise's success can also be attributed to his collaborations with esteemed colleagues such as Takeya Hori and Katsuya Fujimura. Together, they are at the forefront of cancer research, collectively working towards enhanced methods and solutions for complex cancer-related challenges.
Conclusion
Nobuyuki Ise's contributions to oncology through his innovative patents underscore his role as a leading inventor in the field. His efforts to develop effective diagnostic and therapeutic approaches continue to inspire advancements in cancer treatment, showcasing the transformative power of innovation and collaboration in tackling one of humanity’s most challenging diseases.